High Court's Stanford Ruling Puts Special Demands on Life Sciences, Attorneys Say

June 17, 2011

Attorneys and life sciences companies expressed concern that, as a result of the Supreme Court's June 6 ruling that the Bayh-Dole Act does not bar inventors from assigning their individual rights in patents resulting from federally funded research, a research organization's efforts to properly secure rights to that invention will become more complicated and more demands will be placed on life sciences research than on other areas.

Reproduced with permission from Life Sciences Law & Industry Report, 5 LSLR 597 (June 17, 2011). Copyright 2011 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.


Related Publications

November 2020
Explaining the Almost Unexplainable
David Prange, Benjamen Linden, Vivek Biswas - Intellectual Property Magazine
October 2, 2020
Does an AB Rating Fill Out a Skinny Label?
Jeffrey Alan Hovden, Oren D. Langer
September 22, 2020
Herbal Patent Protection
Shui Li - 闻宁阁 American Intellectual Property
August 26, 2020
INSIGHT: Avoiding Trade Secret Claims After Seeing a Competitor’s Crown Jewels
Jake Holdreith, David Prange, Emily Tremblay - Bloomberg Law
Back to Top